Skip to main content
Premium Trial:

Request an Annual Quote

Bayer Schering Pharma Renews License for GeneGo's MetaCore

NEW YORK (GenomeWeb News) — Bayer Schering Pharma has renewed its licenses for GeneGo’s MetaCore software and databases, GeneGo said today.
St. Joseph, Mich.-based GeneGo said that Bayer Schering Pharma has agreed to another three-year license for the software, which is designed for use in target selection and validation, data mining, and for identifying biomarkers for disease states and toxicology. Bayer Schering Pharma is using the software in its oncology, cardiology, and women’s health programs, GeneGo VP of Business Development Julie Bryant said in a statement.
GeneGo also said it is currently developing disease-specific platforms for cancer and cardiovascular studies that “blueprint pathway maps for the disease, processes and mechanisms as well as offering public domain experimental data and disease ontologies.”
Financial terms of the agreement were not released.

Filed under

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.